You have no items in your shopping cart.
In Vitro Diagnostics
In this section you will find Diagnostics In Vitro Diagnostics markets research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities in the biotech, life science and pharmaceutical industries.
| 5 Item(s) | Show per page |
| View as: List Grid |
Sort by
|
Global In Vitro Diagnostic Market Analysis
Published by RNCOS on Dec 1st, 2009
$1,600.00
The In Vitro Diagnostics (IVD) market represents one of the most lucrative segments in the global healthcare industry. Various factors, such as increasing prevalence of several chronic and infectious diseases, emerging technologies and increasing patient awareness Learn More
Innovations in In-Vitro Diagnostics: New technologies, growth opportunities, and the future market outlook
Published by Business Insights on Jun 1st, 2009
$3,835.00
Clinical diagnostics is an attractive and growing industry, with the majority of major diagnostic companies experiencing sales growth of over 10% in 2008, despite significant pricing pressures. However, achieving market growth is becoming increasingly challenging due to the difficulty in developing novel diagnostics for new high value markets, or which can add appreciable clinical benefit in existing markets. Learn More
In Vitro Diagnostics Market Analysis 2009-2024
Published by Visiongain on May 29th, 2009
$2,481.00
New innovative report discusses how the global IVD market will develop in light of commercial opportunities and high technological potential Learn More
Womens Health Diagnostic Testing
Published by TriMark Publications LLC on Aug 1st, 2008
$3,400.00
The purpose of this report is to describe the specific market segment of the in vitro diagnostics market called women’s health testing. Learn More
In Vitro Diagnostics Market Report & Analysis 2008-2023
Published by Visiongain on Jun 25th, 2008
$2,502.00
Visiongain predicts that the markets for IVD and theranostics will exhibit strong growth in revenues from 2008-2023, with significant investments being made by far-sighted companies and healthcare providers.Learn More
| 5 Item(s) | Show per page |
| View as: List Grid |
Sort by
|

